Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.

Dowling C, Firoozi S, Panoulas V, Dalby M, Kashyap MN, Kabir T, Kalogeras K, Buch MH, Levy R, Chowdhary S, Saraf S, Roberts D, More R, Wiper A, Abdelaziz HK, Neylon A, Mylotte D, Pisaniello AD, Fraser DGW, Anderson R, Cunnington MS, Malkin CJ, Blackman DJ, Brennan PF, Owens CG, Manoharan G, Spence MS, Brecker SJ.

Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28512. [Epub ahead of print]

PMID:
31713325
2.

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention.

Krishnamurthy A, Keeble C, Anderson M, Somers K, Burton-Wood N, Harland C, Baxter P, McLenachan J, Blaxill J, Blackman DJ, Malkin C, Wheatcroft S, Greenwood J.

Open Heart. 2019 Jun 29;6(1):e000951. doi: 10.1136/openhrt-2018-000951. eCollection 2019. Erratum in: Open Heart. 2019 Oct 9;6(2):e000951corr1.

3.

Use of the MANTA device to rescue failed pre-closure following transfemoral transcatheter aortic valve implantation.

Ali N, Blackman DJ, Cunnington M, Malkin CJ.

J Cardiol Cases. 2018 Dec 20;19(3):81-84. doi: 10.1016/j.jccase.2018.12.001. eCollection 2019 Mar.

4.

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.

Blackman DJ, Van Gils L, Bleiziffer S, Gerckens U, Petronio AS, Abdel-Wahab M, Werner N, Khogali SS, Wenaweser P, Wöhrle J, Soliman O, Laborde JC, Allocco DJ, Meredith IT, Falk V, Van Mieghem NM.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1116-1123. doi: 10.1002/ccd.28120. Epub 2019 Feb 17.

5.

Long-Term Durability of Transcatheter Aortic Valve Prostheses.

Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, Cunnington MS, Somers K, Brennan P, Manoharan G, Parker J, Aldalati O, Brecker SJ, Dowling C, Hoole SP, Dorman S, Mullen M, Kennon S, Jerrum M, Chandrala P, Roberts DH, Tay J, Doshi SN, Ludman PF, Fairbairn TA, Crowe J, Levy RD, Banning AP, Ruparelia N, Spence MS, Hildick-Smith D.

J Am Coll Cardiol. 2019 Feb 12;73(5):537-545. doi: 10.1016/j.jacc.2018.10.078.

PMID:
30732706
6.

Quantitative Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement With Videodensitometry in a Large, Real-World Study Population: Subanalysis of RESPOND and Echocardiogram Association.

Modolo R, Serruys PW, Chang CC, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Onuma Y, Soliman O, van Mieghem N.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):216-218. doi: 10.1016/j.jcin.2018.11.004. No abstract available.

PMID:
30678802
7.

Silent cerebral infarction and cognitive function following TAVI: an observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve.

Musa TA, Uddin A, Loveday C, Dobson LE, Igra M, Richards F, Swoboda PP, Singh A, Garg P, Foley JRJ, Fent GJ, Goddard AJP, Malkin C, Plein S, Blackman DJ, McCann GP, Greenwood JP.

BMJ Open. 2019 Jan 21;9(1):e022329. doi: 10.1136/bmjopen-2018-022329.

8.

Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.

Van Mieghem NM, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Meredith IT, Falk V.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):38-49. doi: 10.1016/j.jcin.2018.10.052.

9.

Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.

Dowling C, Firoozi S, Doyle N, Blackman DJ, Malkin CJ, Cunnington MS, Saraf S, Buch MH, Levy R, Chowdhary S, Spence MS, Manoharan G, Owens CG, Brennan PF, Roberts D, More R, Wiper A, Abdelaziz HK, Mylotte D, Neylon A, Martin N, Mercanti F, Dorman S, Panoulas V, Dalby M, Kashyap MN, Kabir T, Kovac J, Kontoprias K, Malik IS, Ghada MW, Sen S, Ruparelia N, Demir OM, Frame A, Uren NG, Anderson R, Rajathurai T, Tapp L, Deegan L, Grech E, Hall I, Neville M, Rampat R, Hildick-Smith D, Mullen M, Kennon S, Chandrala P, Doshi S, Brecker SJ.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):751-757. doi: 10.1002/ccd.27934. Epub 2018 Nov 5.

PMID:
30394657
10.

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS Jr, Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR.

Eur Heart J. 2019 Feb 1;40(5):441-451. doi: 10.1093/eurheartj/ehy590.

PMID:
30357365
11.

Trans-catheter aortic valve implantation without contrast using the Lotus mechanically-expanded heart valve.

Ali N, Saraf S, Schlosshan D, Cunnington M, Malkin CJ, Blackman DJ.

J Cardiol Cases. 2018 Jul 17;18(4):141-144. doi: 10.1016/j.jccase.2018.06.007. eCollection 2018 Oct.

12.

CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome.

Chew PG, Dobson LE, Garg P, Fairbairn TA, Musa TA, Uddin A, Swoboda PP, Foley JR, Fent GJ, Brown LAE, Onciul S, Plein S, Blackman DJ, Greenwood JP.

Int J Cardiovasc Imaging. 2019 Jan;35(1):161-170. doi: 10.1007/s10554-018-1441-y. Epub 2018 Sep 4.

13.

Cardiovascular magnetic resonance assessment of 1st generation CoreValve and 2nd generation Lotus valves.

Musa TA, Uddin A, Dobson LE, Swoboda PP, Garg P, Foley JRJ, Malkin C, Plein S, Blackman DJ, Greenwood JP.

J Interv Cardiol. 2018 Jun;31(3):391-399. doi: 10.1111/joic.12512. Epub 2018 Apr 25.

14.

Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.

van Gils L, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, Van Mieghem NM.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):119-128. doi: 10.1016/j.jcin.2017.10.016.

15.

The impact of transcatheter aortic valve implantation on quality of life: A mixed methods study.

Astin F, Horrocks J, McLenachan J, Blackman DJ, Stephenson J, Closs SJ.

Heart Lung. 2017 Nov - Dec;46(6):432-438. doi: 10.1016/j.hrtlng.2017.08.005. Epub 2017 Oct 3.

PMID:
28985898
16.

Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and race.

Krishnamurthy A, Keeble C, Burton-Wood N, Somers K, Anderson M, Harland C, Baxter PD, McLenachan JM, Blaxill JM, Blackman DJ, Malkin CJ, Wheatcroft SB, Greenwood JP.

Eur Heart J Acute Cardiovasc Care. 2019 Apr;8(3):264-272. doi: 10.1177/2048872617735803. Epub 2017 Oct 5.

17.

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Schofer N, Eschenbach L, Fujita B, Sharma R, Ancona M, Yzeiraj E, Cannata S, Barker C, Davies JE, Frangieh AH, Deuschl F, Podlesnikar T, Asami M, Dhoble A, Chyou A, Masson JB, Wijeysundera HC, Blackman DJ, Rampat R, Taramasso M, Gutierrez-Ibanes E, Chakravarty T, Attizzani GF, Kaneko T, Wong SC, Sievert H, Nietlispach F, Hildick-Smith D, Nombela-Franco L, Conradi L, Hengstenberg C, Reardon MJ, Kasel AM, Redwood S, Colombo A, Kar S, Maisano F, Windecker S, Pilgrim T, Ensminger SM, Prendergast BD, Schofer J, Schaefer U, Bax JJ, Latib A, Makkar RR.

J Am Coll Cardiol. 2017 Aug 29;70(9):1121-1131. doi: 10.1016/j.jacc.2017.07.714.

18.

Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.

Falk V, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Dawkins KD, Van Mieghem NM.

Eur Heart J. 2017 Dec 1;38(45):3359-3366. doi: 10.1093/eurheartj/ehx297.

PMID:
28651336
19.

Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.

Rampat R, Khawaja MZ, Hilling-Smith R, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS, Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.

20.

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients.

Meredith IT, Dumonteil N, Blackman DJ, Tchétché D, Walters DL, Hildick-Smith D, Manoharan G, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Feldman T, Allocco DJ, Dawkins KD.

EuroIntervention. 2017 Sep 20;13(7):788-795. doi: 10.4244/EIJ-D-16-01024.

21.

Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).

Blackman DJ, Meredith IT, Dumonteil N, Tchétché D, Hildick-Smith D, Spence MS, Walters DL, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Houle VM, Allocco DJ, Dawkins KD.

Am J Cardiol. 2017 Jul 15;120(2):292-299. doi: 10.1016/j.amjcard.2017.04.026. Epub 2017 Apr 27.

PMID:
28535962
22.

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort.

Dumonteil N, Meredith IT, Blackman DJ, Tchétché D, Hildick-Smith D, Spence MS, Walters DL, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle VM, Allocco DJ, Dawkins KD.

EuroIntervention. 2017 Sep 20;13(7):796-803. doi: 10.4244/EIJ-D-16-01025.

23.

A risk scoring system to predict coronary stent thrombosis.

Malik N, Banning AS, Belger M, Fakhouri W, Graham-Clarke PL, Banning A, Baumbach A, Blackman DJ, de Belder A, Lefèvre T, Stables R, Zaman A, Gershlick AH.

Curr Med Res Opin. 2017 May;33(5):859-867. doi: 10.1080/03007995.2017.1292680. Epub 2017 Mar 9.

PMID:
28276254
24.

The impact of trans-catheter aortic valve replacement induced left-bundle branch block on cardiac reverse remodeling.

Dobson LE, Musa TA, Uddin A, Fairbairn TA, Bebb OJ, Swoboda PP, Haaf P, Foley J, Garg P, Fent GJ, Malkin CJ, Blackman DJ, Plein S, Greenwood JP.

J Cardiovasc Magn Reson. 2017 Feb 22;19(1):22. doi: 10.1186/s12968-017-0335-9.

25.

Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.

Kalra SS, Firoozi S, Yeh J, Blackman DJ, Rashid S, Davies S, Moat N, Dalby M, Kabir T, Khogali SS, Anderson RA, Groves PH, Mylotte D, Hildick-Smith D, Rampat R, Kovac J, Gunarathne A, Laborde JC, Brecker SJ.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):276-282. doi: 10.1016/j.jcin.2016.11.025.

26.

Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality.

Musa TA, Uddin A, Swoboda PP, Fairbairn TA, Dobson LE, Singh A, Garg P, Steadman CD, Erhayiem B, Kidambi A, Ripley DP, McDiarmid AK, Haaf P, Blackman DJ, Plein S, McCann GP, Greenwood JP.

J Cardiovasc Magn Reson. 2017 Feb 8;19(1):13. doi: 10.1186/s12968-017-0329-7.

27.

Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation.

Dobson LE, Musa TA, Uddin A, Fairbairn TA, Swoboda PP, Ripley DP, Garg P, Evans B, Malkin CJ, Blackman DJ, Plein S, Greenwood JP.

EuroIntervention. 2017 Jun 2;13(2):e153-e160. doi: 10.4244/EIJ-D-16-00558.

29.

Right ventricular function following surgical aortic valve replacement and transcatheter aortic valve implantation: A cardiovascular MR study.

Musa TA, Uddin A, Fairbairn TA, Dobson LE, Steadman CD, Kidambi A, Ripley DP, Swoboda PP, McDiarmid AK, Erhayiem B, Garg P, Blackman DJ, Plein S, McCann GP, Greenwood JP.

Int J Cardiol. 2016 Nov 15;223:639-644. doi: 10.1016/j.ijcard.2016.08.065. Epub 2016 Aug 7.

30.

Acute Reverse Remodelling After Transcatheter Aortic Valve Implantation: A Link Between Myocardial Fibrosis and Left Ventricular Mass Regression.

Dobson LE, Musa TA, Uddin A, Fairbairn TA, Swoboda PP, Erhayiem B, Foley J, Garg P, Haaf P, Fent GJ, Malkin CJ, Blackman DJ, Plein S, Greenwood JP.

Can J Cardiol. 2016 Dec;32(12):1411-1418. doi: 10.1016/j.cjca.2016.04.009. Epub 2016 Apr 26.

31.

Assessment of aortic stiffness by cardiovascular magnetic resonance following the treatment of severe aortic stenosis by TAVI and surgical AVR.

Musa TA, Uddin A, Fairbairn TA, Dobson LE, Sourbron SP, Steadman CD, Motwani M, Kidambi A, Ripley DP, Swoboda PP, McDiarmid AK, Erhayiem B, Oliver JJ, Blackman DJ, Plein S, McCann GP, Greenwood JP.

J Cardiovasc Magn Reson. 2016 Jun 10;18(1):37. doi: 10.1186/s12968-016-0256-z.

32.

Lotus-in-Evolut R transcatheter aortic valve implantation for severe paravalvular leak.

Rashid S, Blackman DJ, Malkin C.

J Cardiol Cases. 2016 Jun 9;14(4):97-99. doi: 10.1016/j.jccase.2016.05.003. eCollection 2016 Oct.

33.

Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study.

Dobson LE, Fairbairn TA, Musa TA, Uddin A, Mundie CA, Swoboda PP, Ripley DP, McDiarmid AK, Erhayiem B, Garg P, Malkin CJ, Blackman DJ, Sharples LD, Plein S, Greenwood JP.

Am Heart J. 2016 May;175:101-11. doi: 10.1016/j.ahj.2016.02.010. Epub 2016 Feb 23.

34.

Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.

Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH.

Eur Heart J. 2016 Jun 21;37(24):1910-9. doi: 10.1093/eurheartj/ehw136. Epub 2016 May 4.

35.

1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384. doi: 10.1016/j.jcin.2015.10.024.

36.

Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience.

Rampat R, Khawaja MZ, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS, Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):367-372. doi: 10.1016/j.jcin.2015.12.012.

37.

The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR).

McCann GP, Khan JN, Greenwood JP, Nazir SA, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH.

Southampton (UK): NIHR Journals Library; 2016 Jan.

38.

Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.

McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH.

J Am Coll Cardiol. 2015 Dec 22;66(24):2713-2724. doi: 10.1016/j.jacc.2015.09.099.

39.

Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry).

Fröhlich GM, Baxter PD, Malkin CJ, Scott DJ, Moat NE, Hildick-Smith D, Cunningham D, MacCarthy PA, Trivedi U, de Belder MA, Ludman PF, Blackman DJ; National Institute for Cardiovascular Outcomes Research.

Am J Cardiol. 2015 Nov 15;116(10):1555-9. doi: 10.1016/j.amjcard.2015.08.035. Epub 2015 Sep 3.

40.

Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.

Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, Meredith IT.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):1359-67. doi: 10.1016/j.jcin.2015.05.015.

41.

Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation.

Grant SW, Hickey GL, Ludman P, Moat N, Cunningham D, de Belder M, Blackman DJ, Hildick-Smith D, Uppal R, Kendall S, Bridgewater B.

Eur J Cardiothorac Surg. 2016 Apr;49(4):1164-73. doi: 10.1093/ejcts/ezv270. Epub 2015 Aug 13.

PMID:
26276837
42.

Reply: Complete Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI: Is It Really What We Should Be Doing?

Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP.

J Am Coll Cardiol. 2015 Jul 21;66(3):332-333. doi: 10.1016/j.jacc.2015.04.067. No abstract available.

43.

Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.

Bulluck H, Fröhlich GM, Mohdnazri S, Gamma RA, Davies JR, Clesham GJ, Sayer JW, Aggarwal RK, Tang KH, Kelly PA, Jagathesan R, Kabir A, Robinson NM, Sirker A, Mathur A, Blackman DJ, Ariti C, Krishnamurthy A, White SK, Meier P, Moon JC, Greenwood JP, Hausenloy DJ.

Clin Cardiol. 2015 May;38(5):259-66. doi: 10.1002/clc.22401.

44.

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP.

J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038.

45.

Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life.

Uddin A, Fairbairn TA, Djoukhader IK, Igra M, Kidambi A, Motwani M, Herzog B, Ripley DP, Musa TA, Goddard AJ, Blackman DJ, Plein S, Greenwood JP.

Circ Cardiovasc Interv. 2015 Mar;8(3):e001913. doi: 10.1161/CIRCINTERVENTIONS.114.001913.

PMID:
25737407
46.

Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.

Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, MacCarthy PA, Cunningham D, Wendler O, Marlee D, Hildick-Smith D, Young CP, Kovac J, Uren NG, Spyt T, Trivedi U, Howell J, Gray H; UK TAVI Steering Committee and the National Institute for Cardiovascular Outcomes Research.

Circulation. 2015 Mar 31;131(13):1181-90. doi: 10.1161/CIRCULATIONAHA.114.013947. Epub 2015 Jan 30.

PMID:
25637628
47.

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry.

Malkin CJ, Long WR, Baxter PD, Gale CP, Wendler O, Monaghan M, Thomas MT, Ludman PF, de Belder MA, Cunningham AD, Moat NE, Blackman DJ; National Institute for Cardiovascular Outcomes Research (NICOR).

EuroIntervention. 2016 Feb;11(10):1161-9. doi: 10.4244/EIJY14M12_12.

48.

Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.

Meredith Am IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Allocco DJ, Dawkins KD.

J Am Coll Cardiol. 2014 Sep 30;64(13):1339-48. doi: 10.1016/j.jacc.2014.05.067.

49.

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Nazir SA, Khan JN, Mahmoud IZ, Greenwood JP, Blackman DJ, Kunadian V, Been M, Abrams KR, Wilcox R, Adgey AA, McCann GP, Gershlick AH.

Trials. 2014 Sep 25;15:371. doi: 10.1186/1745-6215-15-371.

50.

Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry.

Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D, DE Belder MA, Ludman PF; National Institute for Cardiovascular Outcomes Research (NICOR).

J Interv Cardiol. 2014 Feb;27(1):86-95. doi: 10.1111/joic.12084. Epub 2013 Dec 30.

PMID:
24373048

Supplemental Content

Loading ...
Support Center